Viking Global Investors

Holding/activity history for  Celldex Therapeutics Inc. (CLDX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2022   Q3 0 0 Sell 100.00% 0.29
2022   Q2 2,337,854 0.29 Add 26.60% 0.06 $26.96
2022   Q1 1,846,647 0.26 Add 143.66% 0.15 $34.06
2021   Q4 757,881 0.08 Reduce 0.58% 0.00 $38.64
2021   Q3 762,296 0.11 Buy 0.11 $53.99